Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Sigyn Therapeutics, Inc. (RGNP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Sigyn Therapeutics, Inc."
07/07/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "SIGYN THERAPEUTICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK THE UNDERSIGNED DOES HEREBY CERTIFY, on behalf of Sigyn Therapeutics, Inc., a Delaware corporation , that the following resolution was duly adopted by the board of directors of the Corporation , in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, as amended on June 23, 2023, which resolution provides for the creation of a series of the Corporation’ s Preferred Stock, par value $0.0001 per share, which is designated as “Series A Preferred Stock,” with the rights, preferences, privileges and restrictions set forth therein. WHEREAS, the Amended and Restated Certificate of Incorporation of the Corporation , prov...",
"SHARE FOR WARRANT EXCHANGE AGREEMENT THIS WARRANT EXCHANGE AGREEMENT is made as of the 30 th day of June 2023, by and between Sigyn Therapeutics, Inc., a Delaware corporation located at 2468 Historic Decatur Road, Suite 140, San Diego, CA. 92106, and [Redacted] ."
06/08/2023 8-K Other Events  Interactive Data
04/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Sigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific Officer"
10/05/2022 8-K Quarterly results
03/09/2022 8-K Quarterly results
03/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
10/25/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
05/14/2021 8-K Quarterly results
10/23/2020 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Amendment to the Articles of Incorporation of Issuer"
08/31/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "SHARE EXCHANGE AGREEMENT BY AND AMONG REIGN RESOURCES CORPORATION AND THE PRINCIPAL SHAREHOLDER OF REIGN RESOURCES CORPORATION AND SIGYN THERAPEUTICS INC. AND THE SHAREHOLDERS OF SIGYN THERAPEUTICS INC. Dated as of: August 25, 2020",
"Reign Resources Corporation and Sigyn Therapeutics Announce Definitive Merger Agreement"
08/10/2020 8-K Quarterly results
05/12/2020 8-K Quarterly results
03/16/2020 8-K Quarterly results
01/03/2020 8-K Quarterly results
11/14/2019 8-K Quarterly results
10/03/2019 8-K Quarterly results
10/17/2018 8-K Quarterly results
01/08/2018 8-K Quarterly results
11/16/2017 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Securities Purchase Agreement",
"Form of Secured Convertible Note issued under the Securities Purchase agreement included as",
"Form of Common Stock Purchase Warrant issued under the Securities Purchase Agreement included as"
09/05/2017 8-K Quarterly results
07/03/2017 8-K Form 8-K - Current report
05/30/2017 8-K Form 8-K - Current report
05/24/2017 8-K Form 8-K - Current report
12/02/2016 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
11/04/2016 8-K Form 8-K - Current report
03/14/2016 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from Hartley Moore Accountancy Corporation regarding change in independent registered public accounting firm"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy